Found 12 hits for monomerid = 445252 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 11.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against VEGFR2 (VEGFR2 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR2 pr... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 11.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 3
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 20.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against FGFR3 (FGFR3 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR3 prote... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 3
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 20.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor beta
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 25.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against PDGFRβ (PDGFRβ Kinase Enzyme System: Promega), were evaluated by mixing the... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor beta
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 25.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 30.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against PDGFRα (PDGFRα Kinase Enzyme System: Promega), were evaluated by mixing the... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 30.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 1
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 66.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 1
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 66.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 112 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
RESPIVERT LIMITED
US Patent
| Assay Description The inhibitory activities of compounds of the invention against FGFR1 (FGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR1 prote... |
US Patent US10669235 (2020)
|
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM445252
(US10669235, Example 43 | US11208381, Example 43)Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)N3CCC4(CC3)N(C)CCCNC4=O)c3ccccc3)c2cc1C Show InChI InChI=1S/C35H37N5O5/c1-22-20-27-28(21-26(22)33(43)45-3)38-31(41)29(27)30(23-8-5-4-6-9-23)37-25-12-10-24(11-13-25)32(42)40-18-14-35(15-19-40)34(44)36-16-7-17-39(35)2/h4-6,8-13,20-21,37H,7,14-19H2,1-3H3,(H,36,44)(H,38,41)/b30-29- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 112 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |